Authors:
DILLMAN RO
NAYAK SK
BARTH NM
DELEON C
SCHWARTZBERG LS
SPITLER LE
CHURCH C
OCONNOR AA
BEUTEL LD
Citation: Ro. Dillman et al., CLINICAL-EXPERIENCE WITH AUTOLOGOUS TUMOR-CELL LINES FOR PATIENT-SPECIFIC VACCINE THERAPY IN METASTATIC MELANOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 165-176
Authors:
WEAVER CH
TAUER K
ZHEN B
SCHWARTZBERG LS
HAZELTON B
WEAVER Z
LEWKOW L
ALLEN C
LONGIN K
BUCKNER CD
Citation: Ch. Weaver et al., 2ND ATTEMPTS AT MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH INITIAL LOW CD34+ CELL YIELDS, Journal of hematotherapy, 7(3), 1998, pp. 241-249
Authors:
SCHWARTZBERG LS
WEAVER CH
BIRCH R
MANNER C
TAUER K
BEEKER T
MORGANIHRIG C
MACANENY B
LEFF R
SMITH R
HAINSWORTH J
GRECO T
SCHWERKOSKE J
MURPHY MN
BUCKNER CD
Citation: Ls. Schwartzberg et al., A RANDOMIZED TRIAL OF 2 DOSES OF CYCLOPHOSPHAMIDE WITH ETOPOSIDE AND G-CSF FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN 318 PATIENTS WITH STAGE-II-STAGE-III BREAST-CANCER, Journal of hematotherapy, 7(2), 1998, pp. 141-150
Authors:
SCHWARTZBERG LS
BIRCH R
WEST WH
TAUER KW
WITTLIN F
LEFF R
CAMPOS L
RYMER W
CARTER P
MANGUM M
GRECO FA
HAINSWORTH J
RAEFSKY E
BLANCO R
BUCKNER CD
WEAVER CH
Citation: Ls. Schwartzberg et al., SEQUENTIAL TREATMENT INCLUDING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK STAGE II-III BREAST-CANCER - OUTPATIENT ADMINISTRATION IN COMMUNITY CANCER CENTERS, American journal of clinical oncology, 21(5), 1998, pp. 523-531
Authors:
WEAVER CH
ZHEN B
SCHWARTZBERG LS
LEFF R
MAGEE M
GEIER L
DEATON K
LEWKOW L
BUCKNER CD
Citation: Ch. Weaver et al., PHASE I-II EVALUATION OF RAPID-SEQUENCE TANDEM HIGH-DOSE MELPHALAN WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MULTIPLE-MYELOMA, Bone marrow transplantation, 22(3), 1998, pp. 245-251
Authors:
WEAVER CH
WEST WH
SCHWARTZBERG LS
ALBERICO T
LEFF R
GRECO FA
HAINSWORTH J
BIRCH R
MCANENY B
MAGEE M
RAEFSKY E
KALMAN L
BUCKNER CD
Citation: Ch. Weaver et al., INDUCTION, MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), HIGH-DOSE CHEMOTHERAPY AND PBSC INFUSION IN PATIENTS WITH UNTREATED STAGE-IVBREAST-CANCER - OUTCOMES BY INTENT TO TREAT ANALYSES, Bone marrow transplantation, 19(7), 1997, pp. 661-670
Authors:
WEAVER CH
SCHWARTZBERG LS
HAINSWORTH J
GRECO FA
LI W
BUCKNER CD
WEST WH
Citation: Ch. Weaver et al., TREATMENT-RELATED MORTALITY IN 1000 CONSECUTIVE PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN COMMUNITY CANCER CENTERS, Bone marrow transplantation, 19(7), 1997, pp. 671-678
Authors:
WEAVER CH
POTZ J
REDMOND J
TAUER K
SCHWARTZBERG LS
KAYWIN P
DRAPKIN R
GRANT B
UNGER P
ALLEN C
LONGIN K
ZHEN B
HAZELTON B
BUCKNER CD
Citation: Ch. Weaver et al., ENGRAFTMENT AND OUTCOMES OF PATIENTS RECEIVING MYELOABLATIVE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS WITH A LOW CD34(+) CELL CONTENT, Bone marrow transplantation, 19(11), 1997, pp. 1103-1110
Authors:
WEAVER CH
SCHWARTZBERG LS
BIRCH R
GRECO FA
RHINEHART S
HAINSWORTH J
BEEKER T
PRICE H
GEIER L
FOSTER J
WEST J
HAZELTON B
BUCKNER CD
Citation: Ch. Weaver et al., COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER THE ADMINISTRATION OF CYCLOPHOSPHAMIDE, ETOPOSIDE, AND GRANULOCYTE-COLONY-STIMULATINGFACTOR - AN ANALYSIS OF 497 PATIENTS, Transfusion, 37(9), 1997, pp. 896-903
Authors:
WEAVER CH
SCHWARTZBERG LS
UPTON S
BIRCH R
BUCKNER CD
Citation: Ch. Weaver et al., INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL COMPARING HIGH-ROSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELT) WITH CARMUSTINE, ETOPOSIDE, CYTOSINE-ARABINOSIDE AND CYCLOPHOSPHAMIDE (BEAC) FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL (PBSC) INFUSION IN PATIENTS WITH RELAPSED HODGKINS-DISEASE (HD), Blood, 88(10), 1996, pp. 3883-3883
Authors:
WEAVER CH
SCHWARTZBERG LS
ZHEN B
HAZELTON B
BUCKNER CD
Citation: Ch. Weaver et al., ENGRAFTMENT IN PATIENTS RECEIVING MYELOABLATIVE THERAPY SUPPORTED WITH PBSC HAVING LOW CD34(+) CELL CONTENT, Blood, 88(10), 1996, pp. 454-454
Authors:
SCHWARTZBERG LS
BIRCH R
ANDREWS CR
BURKE L
HAZELTON B
MURPHY MN
BUCKNER CD
WEAVER CH
Citation: Ls. Schwartzberg et al., A NEW DUAL-CHAMBER IMPLANTABLE INJECTION SYSTEM FOR LONG-TERM CANCER-CHEMOTHERAPY AND APHERESIS OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), Blood, 88(10), 1996, pp. 461-461
Citation: Ls. Schwartzberg et al., PROSPECTIVE RANDOMIZED COMPARISON OF HIGH VS INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE BASED MOBILIZATION THERAPY FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), Blood, 88(10), 1996, pp. 1606-1606
Citation: Ch. Weaver et al., INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE ETOPOSIDE AND RHG-CSF FOR MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) IN 497 PATIENTS, Blood, 86(10), 1995, pp. 1603-1603
Authors:
WEAVER CH
WITTLIN F
LEWIS M
SCHWARTZBERG LS
LI W
PALMER P
Citation: Ch. Weaver et al., A PHASE-I TRIAL OF HIGH-DOSE MELPHALAN, MITOXANTRONE AND CARBOPLATIN IN PATIENTS WITH OVARIAN AND BREAST-CANCER, Blood, 86(10), 1995, pp. 3879-3879
Authors:
WEAVER CH
TAUER K
OROURKE M
RHINEHART S
PENDERGRASS K
SCHWARTZBERG LS
LI W
Citation: Ch. Weaver et al., A RANDOMIZED PHASE IIB TRIAL COMPARING HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELT) WITH CARMUSTINE, ETOPOSIDE - CYTOSINE-ARABINOSIDE AND CYCLOPHOSPHAMIDE (BEAC) FOLLOWED BY PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) INFUSION IN PATIENTS WITH RELAPSED LYMPHOID MALIGNANCIES, Blood, 86(10), 1995, pp. 3880-3880